TP53 mutations were enriched in cancer cell lines sensitive to KIF18A inhibition, which suggests that inactivation of the p53 pathway may remove the barrier that guards against CIN cell expansion46. This evidence concerns the gene TP53 and cervical squamous intraepithelial neoplasia.